These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 20858977

  • 21. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease.
    Anchisi D, Borroni B, Franceschi M, Kerrouche N, Kalbe E, Beuthien-Beumann B, Cappa S, Lenz O, Ludecke S, Marcone A, Mielke R, Ortelli P, Padovani A, Pelati O, Pupi A, Scarpini E, Weisenbach S, Herholz K, Salmon E, Holthoff V, Sorbi S, Fazio F, Perani D.
    Arch Neurol; 2005 Nov; 62(11):1728-33. PubMed ID: 16286547
    [Abstract] [Full Text] [Related]

  • 22. Principal component analysis of FDG PET in amnestic MCI.
    Nobili F, Salmaso D, Morbelli S, Girtler N, Piccardo A, Brugnolo A, Dessi B, Larsson SA, Rodriguez G, Pagani M.
    Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2191-202. PubMed ID: 18648805
    [Abstract] [Full Text] [Related]

  • 23. Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects.
    Coutinho AM, Porto FH, Duran FL, Prando S, Ono CR, Feitosa EA, Spíndola L, de Oliveira MO, do Vale PH, Gomes HR, Nitrini R, Brucki SM, Buchpiguel CA.
    Alzheimers Res Ther; 2015 Sep 15; 7(1):58. PubMed ID: 26373380
    [Abstract] [Full Text] [Related]

  • 24. Effects of age on the glucose metabolic changes in mild cognitive impairment.
    Kantarci K, Senjem ML, Lowe VJ, Wiste HJ, Weigand SD, Kemp BJ, Frank AR, Shiung MM, Boeve BF, Knopman DS, Petersen RC, Jack CR.
    AJNR Am J Neuroradiol; 2010 Aug 15; 31(7):1247-53. PubMed ID: 20299441
    [Abstract] [Full Text] [Related]

  • 25. Global cognitive impairment should be taken into account in SPECT-neuropsychology correlations: the example of verbal memory in very mild Alzheimer's disease.
    Rodriguez G, Morbelli S, Brugnolo A, Calvini P, Girtler N, Piccardo A, Dougall NJ, Ebmeier KP, Baron JC, Nobili F.
    Eur J Nucl Med Mol Imaging; 2005 Oct 15; 32(10):1186-92. PubMed ID: 15931515
    [Abstract] [Full Text] [Related]

  • 26. 18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.
    Morbelli S, Bauckneht M, Arnaldi D, Picco A, Pardini M, Brugnolo A, Buschiazzo A, Pagani M, Girtler N, Nieri A, Chincarini A, De Carli F, Sambuceti G, Nobili F.
    Eur J Nucl Med Mol Imaging; 2017 Nov 15; 44(12):2073-2083. PubMed ID: 28785843
    [Abstract] [Full Text] [Related]

  • 27. Tracking the progression of Alzheimer's disease: Insights from metabolic patterns of SOMI stages.
    Brugnolo A, Orso B, Girtler N, Ferraro PM, Arnaldi D, Mattioli P, Massa F, Famà F, Argenti L, Biffa G, Morganti W, Buonopane S, Uccelli A, Morbelli S, Pardini M.
    Cortex; 2024 Feb 15; 171():413-422. PubMed ID: 38113612
    [Abstract] [Full Text] [Related]

  • 28. Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology.
    Silva-Rodríguez J, Labrador-Espinosa MA, Moscoso A, Schöll M, Mir P, Grothe MJ, Alzheimer’s Disease Neuroimaging Initiative.
    Brain; 2023 Nov 02; 146(11):4520-4531. PubMed ID: 37284793
    [Abstract] [Full Text] [Related]

  • 29. Visual versus semi-quantitative analysis of 18F-FDG-PET in amnestic MCI: an European Alzheimer's Disease Consortium (EADC) project.
    Morbelli S, Brugnolo A, Bossert I, Buschiazzo A, Frisoni GB, Galluzzi S, van Berckel BN, Ossenkoppele R, Perneczky R, Drzezga A, Didic M, Guedj E, Sambuceti G, Bottoni G, Arnaldi D, Picco A, De Carli F, Pagani M, Nobili F.
    J Alzheimers Dis; 2015 Nov 02; 44(3):815-26. PubMed ID: 25362041
    [Abstract] [Full Text] [Related]

  • 30. Differential patterns of regional cerebral hypometabolism according to the level of cerebral amyloid deposition in patients with amnestic mild cognitive impairment.
    Jeon SY, Yi D, Byun MS, Choi HJ, Kim HJ, Lee JH, Baek H, Choe YM, Lee Y, Woo JI, Lee DY.
    Neurosci Lett; 2016 Oct 06; 632():104-8. PubMed ID: 27574728
    [Abstract] [Full Text] [Related]

  • 31. Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD).
    Bauckneht M, Chincarini A, Piva R, Arnaldi D, Girtler N, Massa F, Pardini M, Grazzini M, Efeturk H, Pagani M, Sambuceti G, Nobili F, Morbelli S.
    Alzheimers Res Ther; 2018 Apr 03; 10(1):35. PubMed ID: 29615111
    [Abstract] [Full Text] [Related]

  • 32. Cognitive and functional neuroimaging correlate for anosognosia in mild cognitive impairment and Alzheimer's disease.
    Vogel A, Hasselbalch SG, Gade A, Ziebell M, Waldemar G.
    Int J Geriatr Psychiatry; 2005 Mar 03; 20(3):238-46. PubMed ID: 15717342
    [Abstract] [Full Text] [Related]

  • 33. Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment.
    Wu X, Chen K, Yao L, Ayutyanont N, Langbaum JB, Fleisher A, Reschke C, Lee W, Liu X, Alexander GE, Bandy D, Foster NL, Thompson PM, Harvey DJ, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM, Alzheimer's Disease Neuroimaging Initiative.
    J Neurosci Methods; 2010 Oct 15; 192(2):277-85. PubMed ID: 20678521
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of the posterior cingulate region with FDG-PET and advanced MR techniques in patients with amnestic mild cognitive impairment: comparison of the methods.
    Zimny A, Bladowska J, Macioszek A, Szewczyk P, Trypka E, Wojtynska R, Noga L, Leszek J, Sasiadek M.
    J Alzheimers Dis; 2015 Oct 15; 44(1):329-38. PubMed ID: 24614904
    [Abstract] [Full Text] [Related]

  • 35. [Relationship between episodic memory and resting-state brain functional connectivity network in patients with Alzheimer's disease and mild cognition impairment].
    Wu QJ, Guo ZJ, Liu SE, Yu HQ, Chen J, Yang HM.
    Zhonghua Yi Xue Za Zhi; 2013 Jun 18; 93(23):1795-800. PubMed ID: 24124712
    [Abstract] [Full Text] [Related]

  • 36. Differential hypometabolism patterns according to mild cognitive impairment subtypes.
    Jauhiainen AM, Kangasmaa T, Rusanen M, Niskanen E, Tervo S, Kivipelto M, Vanninen RL, Kuikka JT, Soininen H.
    Dement Geriatr Cogn Disord; 2008 Jun 18; 26(6):490-8. PubMed ID: 18987469
    [Abstract] [Full Text] [Related]

  • 37. Egocentric and allocentric memory as assessed by virtual reality in individuals with amnestic mild cognitive impairment.
    Weniger G, Ruhleder M, Lange C, Wolf S, Irle E.
    Neuropsychologia; 2011 Feb 18; 49(3):518-27. PubMed ID: 21185847
    [Abstract] [Full Text] [Related]

  • 38. Regional amyloid deposition in amnestic mild cognitive impairment and Alzheimer's disease evaluated by [18F]AV-45 positron emission tomography in Chinese population.
    Huang KL, Lin KJ, Hsiao IT, Kuo HC, Hsu WC, Chuang WL, Kung MP, Wey SP, Hsieh CJ, Wai YY, Yen TC, Huang CC.
    PLoS One; 2013 Feb 18; 8(3):e58974. PubMed ID: 23516589
    [Abstract] [Full Text] [Related]

  • 39. Unawareness of deficits in Alzheimer's disease: role of the cingulate cortex.
    Amanzio M, Torta DM, Sacco K, Cauda F, D'Agata F, Duca S, Leotta D, Palermo S, Geminiani GC.
    Brain; 2011 Apr 18; 134(Pt 4):1061-76. PubMed ID: 21385751
    [Abstract] [Full Text] [Related]

  • 40. Correlation between cognitive deficits and glucose hypometabolism in mild cognitive impairment.
    Nishi H, Sawamoto N, Namiki C, Yoshida H, Dinh HD, Ishizu K, Hashikawa K, Fukuyama H.
    J Neuroimaging; 2010 Jan 18; 20(1):29-36. PubMed ID: 19018949
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.